Therefore, NCAPD3 knockdown may inhibit CCND1 and ESR1 expression to downregulate CDK6 and IRSI expression, thereby inhibiting the proliferation of gastric cancer cells. The gene discussed is NCAPD3; the disease is gastric cancer.